Analysis of single-cell sequencing data reveals metabolic reprogramming characterized by high PDK4 expression in non-inflammatory myocardial fibrosis

Authors: Yan, Longxin; Yang, Song; Wang, Xinbo; Chen, Lang; Hu, Bing; Gong, Lili; Liu, Lihong

Source journal: Translational research : the journal of laboratory and clinical medicine (2026-11-18)

DOI: 10.1016/j.trsl.2026.11.003

Abstract

Myocardial infarction (MI) is a metabolic disorder that poses a notable threat to human health, with post-MI heart failure (HF) markedly affecting patient prognosis. The overactivation of inflammation and fibrosis serves an important role in the progression of post-MI HF; however, the underlying mechanisms remain poorly understood. The present study aimed to investigate the associations among metabolic reprogramming, inflammation and fibrosis after MI. By integrating single-nucleus RNA sequencing and spatial transcriptomics data from MI and dilated cardiomyopathy, a common metabolic feature, glycolysis, was identified. This feature was shared by cardiomyocytes and monocytes in myocardial infarction and was specifically localized to the peri-infarct region. Pyruvate dehydrogenase kinase 4 was identified as a core gene linking metabolic reprogramming to fibrosis. A mouse model of MI was established by permanent ligation of the left anterior descending coronary artery. PDK4 knockout was applied to evaluate its role in post-infarction fibrotic remodeling. Furthermore, the results of the present study revealed a cross-cellular metabolic reprogramming process mediating chronic inflammatory cell interactions. In conclusion, the findings of the present study suggested that targeting metabolic reprogramming may offer a promising strategy for preventing inflammation and fibrosis to mitigate post-MI HF.

Read the full text

Related topics

Related open access articles

Abstract and bibliographic data from PubMed (U.S. National Library of Medicine). Copyright of the abstract belongs to the original publisher or authors.